|Videos|June 15, 2022
Clinical Implications of the TIVO-3 Trial
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
5